Received Jul 20, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
| COVID19 | COVID19 (COVID19 (UNKNOWN)) | UNKNOWN MANUFACTURER | UNK | — | — |
a flare-up after receiving covid vaccinations; This is a spontaneous report received from an Other HCP from License Party. Other Case identifier(s): 2026SA0102639 (Sanofi Aventis), PV202600051222 (Sanofi Aventis). A 91-year-old male patient received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation; COVID-19 vaccine prot. subunit (nvx cov 2373) (NUVAXOVID), as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CONDITION AGGRAVATED (non-serious), outcome "unknown", described as "a flare-up after receiving covid vaccinations". Batch/lot number is not provided, and it cannot be obtained.